Spots Global Cancer Trial Database for apixaban
Every month we try and update this database with for apixaban cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy | NCT03080883 | Cerebral Vein T... Deep Vein Throm... Hematopoietic a... Malignant Solid... Metastatic Mali... Pulmonary Embol... Splanchnic Vein... | Apixaban | 18 Years - | Academic and Community Cancer Research United | |
| Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis | NCT04462003 | Deep Vein Throm... Malignancy | Apixaban Enoxaparin | 20 Years - 80 Years | Beni-Suef University | |
| A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | NCT05171049 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Apixaban | 18 Years - | Anthos Therapeutics, Inc. | |
| A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma | NCT02749617 | Anti-Xa Activit... | apixaban | 19 Years - | University of British Columbia | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis | NCT04462003 | Deep Vein Throm... Malignancy | Apixaban Enoxaparin | 20 Years - 80 Years | Beni-Suef University | |
| Anticoagulation in Patients With Venous Thromboembolism and Cancer | NCT04618913 | Neoplasms Embolism | Apixaban Rivaroxaban Edoxaban Dabigatran VKA LMWH | 18 Years - | Pfizer | |
| Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy | NCT04191928 | Pancreas Cancer DVT Pulmonary Embol... | Apixaban | 18 Years - 65 Years | Thomas Jefferson University | |
| Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma | NCT02958969 | Venous Thromboe... Multiple Myelom... | Apixaban | 18 Years - | Dana-Farber Cancer Institute | |
| Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients | NCT03100071 | Cancer Patients Central Venous ... Upper Extremity... | Apixaban | 18 Years - | Lawson Health Research Institute | |
| Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy | NCT03080883 | Cerebral Vein T... Deep Vein Throm... Hematopoietic a... Malignant Solid... Metastatic Mali... Pulmonary Embol... Splanchnic Vein... | Apixaban | 18 Years - | Academic and Community Cancer Research United | |
| Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer | NCT03045406 | Venous Thromboe... | Apixaban Dalteparin | 18 Years - | Fadoi Foundation, Italy | |
| Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma | NCT02958969 | Venous Thromboe... Multiple Myelom... | Apixaban | 18 Years - | Dana-Farber Cancer Institute | |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | NCT02585713 | Cerebral Vein T... Deep Vein Throm... Gonadal Thrombo... Hepatic Thrombo... Malignant Neopl... Mesenteric Thro... Metastatic Mali... Portal Vein Thr... Pulmonary Embol... Renal Vein Thro... Splenic Thrombo... Venous Thromboe... | Apixaban Dalteparin Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
| An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism) | NCT05461807 | Treatment of Ve... Venous Thromboe... Cancer | Rivaroxaban (Xa... Apixaban | 18 Years - | Bayer | |
| Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban | NCT04895553 | Glioma, Maligna... | Observation of ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Venous Thromboembolism Prevention in Outpatients With Glioma | NCT05683808 | Glioblastoma Astrocytoma Venous Thromboe... | Apixaban | 18 Years - | University of Vermont Medical Center | |
| A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase | NCT02369653 | Lymphoma Acute Lymphobla... | Apixaban No systemic ant... | 1 Year - 17 Years | Bristol-Myers Squibb | |
| Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus | NCT03083782 | Venous Thromboe... Pharmacokinetic... Healthy | Apixaban alone Cyclosporine Tacrolimus Apixaban Apixaban | 18 Years - 55 Years | Thomas Jefferson University | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| Venous Thromboembolism Prevention in Outpatients With Glioma | NCT05683808 | Glioblastoma Astrocytoma Venous Thromboe... | Apixaban | 18 Years - | University of Vermont Medical Center | |
| A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | NCT05171049 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Apixaban | 18 Years - | Anthos Therapeutics, Inc. | |
| API-CAT STUDY for APIxaban Cancer Associated Thrombosis | NCT03692065 | Cancer-associat... | Apixaban 5 MG | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients | NCT02048865 | Venous Thromboe... Cancer | Apixaban Placebo drug | 18 Years - | Ottawa Hospital Research Institute | |
| Anticoagulation in Patients With Venous Thromboembolism and Cancer | NCT04618913 | Neoplasms Embolism | Apixaban Rivaroxaban Edoxaban Dabigatran VKA LMWH | 18 Years - | Pfizer | |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | NCT02585713 | Cerebral Vein T... Deep Vein Throm... Gonadal Thrombo... Hepatic Thrombo... Malignant Neopl... Mesenteric Thro... Metastatic Mali... Portal Vein Thr... Pulmonary Embol... Renal Vein Thro... Splenic Thrombo... Venous Thromboe... | Apixaban Dalteparin Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
| Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients | NCT03100071 | Cancer Patients Central Venous ... Upper Extremity... | Apixaban | 18 Years - | Lawson Health Research Institute | |
| Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study | NCT02581176 | Neoplasms Venous Thrombos... | Apixaban | 18 Years - | University Hospital, Akershus |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
